Literature DB >> 84919

Experimental Lassa fever virus infection successfully treated with ribavirin.

E L Stephen, P B Jahrling.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1979        PMID： 84919     DOI： 10.1016/s0140-6736(79)90790-6

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  13 in total

1.  Genomic profiling of host responses to Lassa virus: therapeutic potential from primate to man.

Authors:  Juan C Zapata; Maria S Salvato
Journal:  Future Virol       Date:  2015-03-13       Impact factor: 1.831

Review 2.  Progress in the experimental therapy of severe arenaviral infections.

Authors:  Brian B Gowen; Mike Bray
Journal:  Future Microbiol       Date:  2011-12       Impact factor: 3.165

Review 3.  Lymphocytic choriomeningitis virus (LCMV) infection of macaques: a model for Lassa fever.

Authors:  Juan C Zapata; C David Pauza; Mahmoud M Djavani; Juan D Rodas; Dmitry Moshkoff; Joseph Bryant; Eugene Ateh; Cybele Garcia; Igor S Lukashevich; Maria S Salvato
Journal:  Antiviral Res       Date:  2011-07-27       Impact factor: 5.970

4.  Plasma disappearance, urine excretion, and tissue distribution of ribavirin in rats and rhesus monkeys.

Authors:  E A Ferrara; J S Oishi; R W Wannemacher; E L Stephen
Journal:  Antimicrob Agents Chemother       Date:  1981-06       Impact factor: 5.191

5.  Sensitive radioimmunoassay for the broad-spectrum antiviral agent ribavirin.

Authors:  R K Austin; P E Trefts; M Hintz; J D Connor; M F Kagnoff
Journal:  Antimicrob Agents Chemother       Date:  1983-11       Impact factor: 5.191

6.  Inhibition of lymphocyte proliferative responses by ribavirin.

Authors:  D L Peavy; W C Koff; D S Hyman; V Knight
Journal:  Infect Immun       Date:  1980-08       Impact factor: 3.441

7.  Recombinant Lassa Virus Expressing Green Fluorescent Protein as a Tool for High-Throughput Drug Screens and Neutralizing Antibody Assays.

Authors:  Yíngyún Caì; Masaharu Iwasaki; Brett F Beitzel; Shuīqìng Yú; Elena N Postnikova; Beatrice Cubitt; Lisa Evans DeWald; Sheli R Radoshitzky; Laura Bollinger; Peter B Jahrling; Gustavo F Palacios; Juan C de la Torre; Jens H Kuhn
Journal:  Viruses       Date:  2018-11-20       Impact factor: 5.818

Review 8.  Review of the literature and proposed guidelines for the use of oral ribavirin as postexposure prophylaxis for Lassa fever.

Authors:  Daniel G Bausch; Christiane M Hadi; Sheik Humarr Khan; Juan J L Lertora
Journal:  Clin Infect Dis       Date:  2010-11-08       Impact factor: 9.079

9.  Attenuation of Live-Attenuated Yellow Fever 17D Vaccine Virus Is Localized to a High-Fidelity Replication Complex.

Authors:  Emily H Davis; Andrew S Beck; Ashley E Strother; Jill K Thompson; Steven G Widen; Stephen Higgs; Thomas G Wood; Alan D T Barrett
Journal:  mBio       Date:  2019-10-22       Impact factor: 7.867

Review 10.  Animal Models for the Study of Rodent-Borne Hemorrhagic Fever Viruses: Arenaviruses and Hantaviruses.

Authors:  Joseph W Golden; Christopher D Hammerbeck; Eric M Mucker; Rebecca L Brocato
Journal:  Biomed Res Int       Date:  2015-07-21       Impact factor: 3.411
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.